Attached files

file filename
EX-10.7 - EX-10.7 - Nexvet Biopharma plcnvet-ex107_816.htm
EX-10.10 - EX-10.10 - Nexvet Biopharma plcnvet-ex1010_784.htm
EX-31.2 - EX-31.2 - Nexvet Biopharma plcnvet-ex312_201506307.htm
EX-31.1 - EX-31.1 - Nexvet Biopharma plcnvet-ex311_201506306.htm
EX-32.1 - EX-32.1 - Nexvet Biopharma plcnvet-ex321_201506308.htm
EX-32.2 - EX-32.2 - Nexvet Biopharma plcnvet-ex322_201506309.htm
10-K - 10-K - Nexvet Biopharma plcnvet-10k_20150630.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S‑8 (No. 333-202995) of Nexvet Biopharma public limited company of our report dated September 3, 2015 relating to the financial statements, which appears in this Form 10‑K.

/s/ PricewaterhouseCoopers
Melbourne, Australia
September 3, 2015